H19 was also found to be overexpressed in drug-resistant cell lines, such as doxorubicin-resistant breast- and liver cancer cells30, 31 and a cisplatin-resistant ovarian cancer cell line32. This evidence concerns the gene H19 and ovarian carcinoma.